{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:24:46Z","timestamp":1783347886697,"version":"3.54.6"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Oral squamous cell carcinoma (OSCC) is an ulceroproliferative lesion that can affect the oral mucosa, from the lips to the oropharynx. OSCC is initiated in part by precancerous disorders of the oral mucosa, particularly those associated with moderate to severe dysplasia. It is well known that, depending on the stage of carcinogenesis, transforming growth factor beta one (TGF-\u03b21) can act as a tumour supporter or controller. The expression of TGF-\u03b21 has been linked to the pathophysiology of numerous illnesses, such as fibrosis and cancer. High-risk metastasis to lymph nodes (cervical) and elevated risk of local invasiveness are the main features of OSCC. The present study aims to examine and compare the immuno-expression of TGF-\u03b21 in oral epithelial dysplasia (OED) and OSCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>To analyze and compare the IHC expression of TGF-\u03b21 in OED and OSCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>The current study was performed after approval from the Institutional Ethical Committee of VMSDC, Salem. The study sample size was determined to be 40, comprising archival blocks: 10 histopathologically confirmed cases of OED, and 30 histopathologically confirmed cases of various grades of OSCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The expression of TGF-\u03b21-labelled cells was higher in well-differentiated (Grade 1) OSCC followed by moderately differentiated (Grade 2) and poorly differentiated (Grade 3) OSCC, on comparing TGF-\u03b21 expression and the total percentage of staining intensity between OSCC and OED. OSCC showed the highest expression and the staining intensity of TGF-\u03b21. One-way ANOVA, Chi-square test, and independent\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -test were among the statistical tests employed. The quantity of positive tumour cells and the staining intensity were noted. Arithmetic means and standard deviations were calculated for multiple values. The Analysis of Variance (ANOVA) allowed for a correlation of the outcomes regarding immunoreactivity (total score). A\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      value that was greater than 0.05 was considered non-significant. For the comparison of TGF-\u03b21 expression between the groups, an independent\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -test was used.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>\n                      The current study aimed to examine the expression of TGF-\u03b21 by IHC between various OSCC grades and OED. TGF-\u03b21 immunoexpression was seen to be increasing from OED to OSCC and was highest in well-differentiated tumours. Although the differences between OSCC grades were not statistically significant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05), the overall higher expression in OSCC supports a potential role of TGF-\u03b21 in tumour differentiation, angiogenesis and progression.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jomfp.jomfp_140_25","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:00:22Z","timestamp":1783101622000},"page":"202-208","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Comparative immunohistochemical expression of transforming growth factor beta one (TGF-\u03b21) in oral epithelial dysplasia and oral squamous cell carcinoma"],"prefix":"10.4103","volume":"30","author":[{"given":"S","family":"Sowndarya","sequence":"first","affiliation":[{"name":"Department of Oral and Maxillofacial Pathology and Oral Microbiology, Vinayaka Mission\u2019s Sankarachariyar Dental College, Vinayaka Mission\u2019s Research Foundation (Deemed to be University), Ariyanoor, Salem, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Ramesh","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Pathology and Oral Microbiology, Vinayaka Mission\u2019s Sankarachariyar Dental College, Vinayaka Mission\u2019s Research Foundation (Deemed to be University), Ariyanoor, Salem, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarthisri","family":"Chandran","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Pathology and Oral Microbiology, Vinayaka Mission\u2019s Sankarachariyar Dental College, Vinayaka Mission\u2019s Research Foundation (Deemed to be University), Ariyanoor, Salem, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidya Srinidhi","family":"Sakthivel","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Pathology and Oral Microbiology, Vinayaka Mission\u2019s Sankarachariyar Dental College, Vinayaka Mission\u2019s Research Foundation (Deemed to be University), Ariyanoor, Salem, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indra","family":"Priyadarshini","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Pathology and Oral Microbiology, Vinayaka Mission\u2019s Sankarachariyar Dental College, Vinayaka Mission\u2019s Research Foundation (Deemed to be University), Ariyanoor, Salem, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayabalan","family":"Ravi","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Pathology and Oral Microbiology, Vinayaka Mission\u2019s Sankarachariyar Dental College, Vinayaka Mission\u2019s Research Foundation (Deemed to be University), Ariyanoor, Salem, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"R1-20260706","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1158\/1055-9965.EPI-22-0114","article-title":"Oral cancer prevalence, mortality, and costs in Medicaid and commercial insurance claims data","volume":"31","author":"Tranby","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R2-20260706","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.18203\/2394-6040.ijcmph20172524","article-title":"Oral cancer epidemiology of Aurangabad district (Maharashtra) of India from 2005 to 2014: Understanding the burden of disease","volume":"4","author":"Niranjan","year":"2017","journal-title":"Int J Community Med Public Health"},{"key":"R3-20260706","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1875-595x.2012.00131.x","article-title":"Oral cancer in India continues in epidemic proportions: Evidence-based and policy initiatives","volume":"63","author":"Gupta","year":"2013","journal-title":"Int Dent J"},{"key":"R4-20260706","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/1471-2407-9-260","article-title":"Malignant transformation of oral potentially malignant disorders in males: A retrospective cohort study","volume":"9","author":"Ho","year":"2009","journal-title":"BMC Cancer"},{"key":"R5-20260706","first-page":"4085","article-title":"Oral proliferative verrucous leukoplakia: Progression to malignancy and clinical implications","volume":"13","author":"Palaia","year":"2021","journal-title":"Systematic review and meta-analysis, Cancers (Basel)"},{"key":"R6-20260706","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pathol.2023.10.002","article-title":"Demystifying oral epithelial dysplasia: A histological guide","volume":"56","author":"Hankinson","year":"2024","journal-title":"Pathology"},{"key":"R8-20260706","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41421-023-00532-4","article-title":"Single-cell and spatial dissection of precancerous lesions underlying the initiation process of oral squamous cell carcinoma","volume":"9","author":"Sun","year":"2023","journal-title":"Cell Discov"},{"key":"R9-20260706","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/hed.10120","article-title":"Histopathologic parameters in the evaluation of T1 squamous cell carcinomas of the oral cavity","volume":"24","author":"Bundgaard","year":"2002","journal-title":"Head Neck"},{"key":"R10-20260706","first-page":"317","article-title":"Molecular metastases markers in head and neck squamous cell carcinoma: Review of the literature","volume":"26","author":"Cortesina","year":"2006","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"R12-20260706","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","article-title":"Mechanisms of TGF-\u03b2signaling from cell membrane to the nucleus","volume":"113","author":"Shi","year":"2003","journal-title":"Cell"},{"key":"R13-20260706","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1046\/j.1471-4159.2000.0752227.x","article-title":"The transforming growth factor-\u03b2s: Structure, signaling, and roles in nervous system development and functions","volume":"75","author":"B\u00f6ttner","year":"2000","journal-title":"J Neurochem"},{"key":"R14-20260706","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/path.2785","article-title":"The dynamic roles of TGF-\u03b2in cancer","volume":"223","author":"Meulmeester","year":"2011","journal-title":"J Pathol"},{"key":"R15-20260706","doi-asserted-by":"crossref","first-page":"739","DOI":"10.21608\/edj.2016.95099","article-title":"Enhanced expression of transforming growth factor beta one (Tgf-\u03b21) during progression of oral epithelial dysplasia to carcinoma","volume":"62","author":"Essa","year":"2016","journal-title":"Egypt Dental J"},{"key":"R16-20260706","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1677\/joe.0.1610041","article-title":"Vascular endothelial growth factor gene and protein: Strong expression in thyroiditis and thyroid carcinoma;","volume":"161","author":"Klein","year":"1999","journal-title":"Journal of Endocrinology"},{"key":"R17-20260706","doi-asserted-by":"crossref","first-page":"100195","DOI":"10.1016\/j.oor.2024.100195","article-title":"Expression analysis of transforming growth factor beta (TGF-\u03b2) in oral squamous cell carcinoma","volume":"9","author":"Ganesh","year":"2024","journal-title":"Oral Oncol Rep"},{"key":"R18-20260706","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/odi.15008","article-title":"Clinical aspects of oral cancer and potentially malignant disorders in South and Southeast Asia","volume":"31","author":"Ranganathan","year":"2025","journal-title":"Oral Dis"},{"key":"R19-20260706","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1600-0714.2006.00491.x","article-title":"Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: A follow-up study based in a Taiwanese hospital","volume":"36","author":"Hsue","year":"2007","journal-title":"J Oral Pathol Med"},{"key":"R20-20260706","first-page":"6675208","article-title":"The role of TGF-\u03b2signaling pathways in cancer and its potential as a therapeutic target","author":"Yang","year":"2021","journal-title":"Evid Based Complement Alternat Med 2021"},{"key":"R21-20260706","first-page":"542","article-title":"Transforming growth factor-\u00df1 and-\u00df2 in gastric precancer and cancer and roles in tumor-cell interactions with peripheral blood mononuclear cells in vitro","volume":"8","author":"Ma","year":"2013","journal-title":"PLoS One"},{"key":"R22-20260706","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semcdb.2019.12.010","article-title":"TGF-\u03b21\u2013a truly transforming growth factor in fibrosis and immunity","volume":"101","author":"Lodyga","year":"2020","journal-title":"Semin Cell Dev Biol"},{"key":"R23-20260706","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00268-009-0070-y","article-title":"Overexpression and interactions of interleukin-10, transforming growth factor \u03b2, and vascular endothelial growth factor in esophageal squamous cell carcinoma","volume":"33","author":"Gholamin","year":"2009","journal-title":"World J Surg"},{"key":"R24-20260706","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/carcin\/bgn164","article-title":"Influence of interleukin- 8 and interleukin-10 on sporadic colon cancer development and progression","volume":"29","author":"\u010ca\u010dev","year":"2008","journal-title":"Carcinogenesis"},{"key":"R25-20260706","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1158\/1078-0432.CCR-11-2557","article-title":"Loss of transforming growth factor beta type II receptor increases aggressive tumour behaviour and reduces survival in lung adenocarcinoma and squamous cell carcinoma","volume":"18","author":"Malkoski","year":"2012","journal-title":"Clin Cancer Res"},{"key":"R26-20260706","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.humimm.2014.11.002","article-title":"Immunosuppressive mediators of oral squamous cell carcinoma in tumour samples and saliva","volume":"76","author":"Gon\u00e7alves","year":"2015","journal-title":"Hum Immunol"},{"key":"R27-20260706","doi-asserted-by":"crossref","first-page":"739","DOI":"10.21608\/edj.2016.95099","article-title":"Enhanced expression of Transforming Growth Factor Beta One (TGF-\u03b21) during progression of oral epithelial dysplasia to carcinoma","volume":"62","author":"Ahmed Abdelaziz","year":"2016","journal-title":"Egyptian Dental Journal"},{"key":"R28-20260706","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jso.10273","article-title":"Decreased expression of human papillomavirus E2 protein and transforming growth factor-\u03b21 in human cervical neoplasia as an early marker in carcinogenesis","volume":"84","author":"Torng","year":"2003","journal-title":"J Surg Oncol"},{"key":"R29-20260706","doi-asserted-by":"crossref","first-page":"8475","DOI":"10.1038\/s41598-020-65145-3","article-title":"MED15, transforming growth factor beta 1 (TGF- \u03b21), Fc\u03b3RIII (CD16), and HNK-1 (CD57) are prognostic biomarkers of oral squamous cell carcinoma","volume":"10","author":"Elahi","year":"2020","journal-title":"Sci Repo"},{"key":"R30-20260706","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.kjms.2014.12.003","article-title":"TGF- \u03b21 and IL-10 single nucleotide polymorphisms as risk factors for oral cancer in Taiwanese","volume":"31","author":"Hsu","year":"2015","journal-title":"Kaohsiung J Med Sci"},{"key":"R31-20260706","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2407-11-88","article-title":"Downregulation of TGF-beta receptor types II and III in oral squamous cell carcinoma and oral carcinoma-associated fibroblasts","volume":"11","author":"Meng","year":"2011","journal-title":"BMC Cancer"},{"key":"R32-20260706","doi-asserted-by":"crossref","first-page":"10263","DOI":"10.3390\/ijms241210263","article-title":"TGF-\u03b2Signaling in Progression of Oral Cancer","volume":"24","author":"Guo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R33-20260706","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.3892\/ol.2013.1302","article-title":"Role of inflammation in oral carcinogenesis (Part II): CD8, FOXP3, TNF-\u03b1, TGF-\u03b2and NF-\u03baB expression","volume":"5","author":"Piva","year":"2013","journal-title":"Oncol Lett"},{"key":"R34-20260706","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2613.2011.00806.x","article-title":"Transforming growth factor-\u03b2enhances invasion and metastasis in Ras-transfected human malignant epidermal keratinocytes","volume":"93","author":"Davies","year":"2012","journal-title":"Int J Exp Pathol"},{"key":"R35-20260706","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.bbrc.2015.02.013","article-title":"Transforming growth factor-\u03b2synthesized by stromal cells and cancer cell participates in bone resorption induced by oral squamous cell carcinoma","volume":"458","author":"Nakamura","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"R36-20260706","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1087-0024.2005.200403.x","article-title":"Current view of the role of transforming growth factor \u03b21 in skin carcinogenesis","volume":"10","author":"Li","year":"2005","journal-title":"J Investig Dermatol Symp Proc"}],"container-title":["Journal of Oral and Maxillofacial Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/jomfp.jomfp_140_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T13:48:35Z","timestamp":1783345715000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.4103\/jomfp.jomfp_140_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jomfp.jomfp_140_25","relation":{},"ISSN":["0973-029X","1998-393X"],"issn-type":[{"value":"0973-029X","type":"print"},{"value":"1998-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"2025-05-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}